On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...

Boys and young adult male patients with congenital adrenal hyperplasia receiving glucocorticoid treatment have lower bone mineral density than healthy individuals, an Italian study shows.

The Research Topic has been launched recently. Authors will be published on this page as soon as they become available.

Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly ...

If levels are high outside of these situations, it may be due to hormonal medications that cause progesterone levels to spike. It may also be due to medical conditions like ovarian cysts, congenital ...

HBM Alpha Therapeutics Inc. signed a potential $395 million licensing deal Feb. 26 with an unnamed “business partner” for its endocrine asset, HAT-001, adding another contender to the congenital ...